BeiGene, Ltd. (BGNE) financial statements (2022 and earlier)

Company profile

Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
GRAND CAYMAN, KY1-1108
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6,6184,6519831,781838368
Cash and cash equivalents4,3761,38261871324088
Short-term investments2,2423,2693651,069598281
Restricted cash and investments00015  
Receivables50076735329 
Inventory, net of allowances, customer advances and progress billings24389291611 
Inventory24389291611 
Prepaid expense60431920  
Other current assets27     
Other undisclosed current assets1661017059366
Total current assets:7,6144,9611,1731,944913374
Noncurrent Assets
Operating lease, right-of-use asset11791 
Property, plant and equipment5883582421576326
Intangible assets, net (including goodwill)475677 
Goodwill   00 
Intangible assets, net (excluding goodwill)475677 
Restricted cash and investments78213  
Deferred income tax assets11066 
Other noncurrent assets1631136854435
Other undisclosed noncurrent assets  12075201
Total noncurrent assets:1,03264044030613331
TOTAL ASSETS:8,6465,6011,6122,2501,046406
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:8425982991009617
Accounts payable262232122 7012
Accrued liabilities558346164   
Employee-related liabilities   36174
Taxes payable212013 91
Other undisclosed accounts payable and accrued liabilities   65  
Deferred revenue187  
Debt2,725335 99 
Deferred revenue and credits12 
Other undisclosed current liabilities(2,154)142111373318
Total current liabilities:1,6001,07531024615035
Noncurrent Liabilities
Long-term debt and lease obligation2452138341917
Long-term debt, excluding current maturities2021848341917
Operating lease, liability4329 
Liabilities, other than long-term debt289682041882031
Deferred revenue and credits25 
Deferred revenue220  
Deferred income tax liabilities1411 
Due to related parties  157149146 
Other liabilities54574739321
Other undisclosed noncurrent liabilities2703753621  
Total noncurrent liabilities:80365632425021218
Total liabilities:2,4031,73263449636253
Stockholders' equity
Stockholders' equity attributable to parent6,2433,8699621,739670353
Common stock000000
Additional paid in capital11,1917,4152,9262,7451,001591
Accumulated other comprehensive income (loss)187(8)2(0)(1)
Accumulated deficit(4,966)(3,553)(1,956)(1,007)(331)(237)
Stockholders' equity attributable to noncontrolling interest  161414 
Total stockholders' equity:6,2433,8699781,754684353
TOTAL LIABILITIES AND EQUITY:8,6465,6011,6122,2501,046406

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues1,1763094281982381
Revenue, net236 
Cost of revenue
(Cost of Goods and Services Sold)
(165)(71)(71)(29)(5) 
Gross profit:1,0112383571702331
Operating expenses(2,451)(1,896)(1,317)(875)(332)(118)
Other undisclosed operating income1     
Operating loss:(1,439)(1,658)(960)(706)(98)(117)
Nonoperating income
(Other Nonoperating income)
163772110
Interest and debt expense(29)(18)    
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes1420914(4) 
Loss from continuing operations before equity method investments, income taxes:(1,439)(1,618)(944)(690)(91)(117)
Income from equity method investments812    
Other undisclosed loss from continuing operations before income taxes     (3)
Loss from continuing operations before income taxes:(1,431)(1,606)(944)(690)(91)(119)
Income tax expense (benefit)2518(7)16(2)(0)
Loss before gain (loss) on sale of properties:(1,406)(1,589)(951)(674)(93)(119)
Other undisclosed net loss(8)(12)    
Net loss:(1,413)(1,601)(951)(674)(93)(119)
Net income attributable to noncontrolling interest 4200 
Net loss available to common stockholders, diluted:(1,413)(1,597)(949)(674)(93)(119)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(1,413)(1,601)(951)(674)(93)(119)
Other comprehensive income (loss)1115(10)   
Other undisclosed comprehensive income (loss)  (0)211
Comprehensive loss:(1,402)(1,585)(960)(672)(93)(118)
Comprehensive income, net of tax, attributable to noncontrolling interest 3200 
Comprehensive loss, net of tax, attributable to parent:(1,402)(1,582)(958)(672)(93)(118)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: